These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1850249)

  • 1. Antitumor activity of naltrexone and correlation with steroid hormone receptors.
    Abou-Issa H; Tejwani GA
    Biochem Biophys Res Commun; 1991 Mar; 175(2):625-30. PubMed ID: 1850249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.
    Alshafie GA; Abou-Issa HM; Seibert K; Harris RE
    Oncol Rep; 2000; 7(6):1377-81. PubMed ID: 11032948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficacy of the opioid antagonist, naltrexone, on the initiation and promotion phases of rat mammary carcinogenesis.
    Koo KL; Tejwani GA; Abou-Issa H
    Anticancer Res; 1996; 16(4A):1893-8. PubMed ID: 8712718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone.
    Tejwani GA; Gudehithlu KP; Hanissian SH; Gienapp IE; Whitacre CC; Malarkey WB
    Carcinogenesis; 1991 Apr; 12(4):637-41. PubMed ID: 1901524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate antagonists can inhibit mammary tumor growth in rats.
    Aylsworth CF; Hodson CA; Meites J
    Proc Soc Exp Biol Med; 1979 May; 161(1):18-20. PubMed ID: 108682
    [No Abstract]   [Full Text] [Related]  

  • 9. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
    Moreno-Cuevas JE; Sirbasku DA
    In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth.
    Lewis JW; Shavit Y; Terman GW; Nelson LR; Gale RP; Liebeskind JC
    Peptides; 1983; 4(5):635-8. PubMed ID: 6686324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone modulates growth in infant rats.
    Zagon IS; McLaughlin PJ
    Life Sci; 1983 Dec; 33(24):2449-54. PubMed ID: 6316064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 1 alpha,25-dihydroxyvitamin D3 on the development and steroid hormone receptor contents of DMBA-induced rat mammary tumors.
    Noguchi S; Tahara H; Miyauchi K; Koyama H
    Oncology; 1989; 46(4):273-6. PubMed ID: 2500626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the prostaglandin synthetase inhibitor indomethacin on tumorigenesis, tumor proliferation, cell kinetics, and receptor contents of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in Sprague-Dawley rats fed a high- or low-fat diet.
    Noguchi M; Taniya T; Koyasaki N; Kumaki T; Miyazaki I; Mizukami Y
    Cancer Res; 1991 May; 51(10):2683-9. PubMed ID: 1902395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin and stress effect on tumoral growth of 7,12-dimethylbenz[A]anthracene-induced rat mammary tumors.
    Wendel V; Vázquez SM; Durante PC; Lemoine AP; Segura ET; Calandra RS; Luthy IA
    Acta Physiol Pharmacol Ther Latinoam; 1996; 46(4):277-85. PubMed ID: 9222393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats.
    Inano H; Onoda M; Inafuku N; Kubota M; Kamada Y; Osawa T; Kobayashi H; Wakabayashi K
    Carcinogenesis; 2000 Oct; 21(10):1835-41. PubMed ID: 11023541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies.
    Zagon IS; McLaughlin PJ
    Brain Res; 1986 Aug; 393(2):233-46. PubMed ID: 3017514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
    Saarinen NM; Wärri A; Dings RP; Airio M; Smeds AI; Mäkelä S
    Int J Cancer; 2008 Sep; 123(5):1196-204. PubMed ID: 18528864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.